Growth Metrics

Intelligent Bio Solutions (INBS) Cash & Current Investments (2020 - 2023)

Intelligent Bio Solutions has reported Cash & Current Investments over the past 4 years, most recently at $1.1 million for Q4 2023.

  • Quarterly results put Cash & Current Investments at $1.1 million for Q4 2023, down 61.57% from a year ago — trailing twelve months through Dec 2023 was $1.1 million (down 61.57% YoY), and the annual figure for FY2022 was $8.2 million, down 34.48%.
  • Cash & Current Investments for Q4 2023 was $1.1 million at Intelligent Bio Solutions, up from $186401.0 in the prior quarter.
  • Over the last five years, Cash & Current Investments for INBS hit a ceiling of $19.9 million in Q4 2020 and a floor of $186401.0 in Q3 2023.
  • Median Cash & Current Investments over the past 4 years was $8.2 million (2022), compared with a mean of $7.9 million.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 2842.78% in 2021 and later tumbled 96.75% in 2023.
  • Intelligent Bio Solutions' Cash & Current Investments stood at $19.9 million in 2020, then plummeted by 43.7% to $11.2 million in 2021, then tumbled by 73.98% to $2.9 million in 2022, then plummeted by 61.57% to $1.1 million in 2023.
  • The last three reported values for Cash & Current Investments were $1.1 million (Q4 2023), $186401.0 (Q3 2023), and $2.3 million (Q1 2023) per Business Quant data.